As members of the Pigmentary Disorders Academy, we would like to express our comments on the Food and Drug Administration’s (FDA) review of skin-bleaching drug products for over-the-counter (OTC) human use (Docket No. - Ochronosis - Document - PDFSEARCH.IO

First Page	Meta Content
	As members of the Pigmentary Disorders Academy, we would like to express our comments on the Food and Drug Administration’s (FDA) review of skin-bleaching drug products for over-the-counter (OTC) human use (Docket No. Add to Reading List Document Date: 2007-03-20 08:54:07 Open Document File Size: 15,68 KB Share Result on Facebook Continent Europe / / Facility France Dr James Nordlund University of Cincinnati / / IndustryTerm hydroquinone-containing products / treatment of specific pigment disorders / skin-bleaching drug products / non prescription skin bleaching drug products / Skin bleaching drug products / drug products / pharmaceutical quality / skin-bleaching products / / MedicalCondition TB / specific pigment disorders / Pigment disorders / pigmentary disorders / / Organization European Union / University of Cincinnati / Food and Drug Administration / Department of Health / France Dr James Nordlund University / Center for Drug Evaluation / As / Pigmentary Disorders Academy / / Position Professor / / SocialTag Pharmacology Pharmaceuticals policy Food and Drug Administration Drug safety Drugs Skin whitening Hydroquinone Ochronosis Over-the-counter drug Medicine

As members of the Pigmentary Disorders Academy, we would like to express our comments on the Food and Drug Administration’s (FDA) review of skin-bleaching drug products for over-the-counter (OTC) human use (Docket No. Add to Reading List